UK Renal Registry 17th Annual Report: Appendix B Definitions and Analysis Criteria
Author(s) -
Rishi Pruthi,
Anna Casula,
Iain MacPhee,
Julie Gilg,
Damian Fogarty,
Rebecca Evans,
Anirudh Rao,
Andrew J Williams,
David Pitcher,
Richard Fluck,
Mick Kumwenda,
Alexander J Hamilton,
Catherine O'Brien,
Fiona Braddon,
Carol Inward,
Malcolm Lewis,
Heather Maxwell,
Jelena Stojanovic,
Yincent Tse,
Manish D. Sinha,
Elinor Curnow,
Paul Roderick,
Rommel Ravanan,
Clare Castledine,
Retha Steenkamp,
Catriona Shaw,
Andrew Davenport,
Johann Nicholas,
Anne Dawnay,
Fergus Caskey,
John Davies,
Lisa Crowley,
Ken Farrington,
Satz Mengensatzproduktion,
Druckerei Stückle
Publication year - 2015
Publication title -
the nephron journals/nephron journals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.951
H-Index - 72
eISSN - 2235-3186
pISSN - 1660-8151
DOI - 10.1159/000370284
Subject(s) - medicine , appendix , intensive care medicine , paleontology , biology
The take-on population is defined as all patients over 18 who started renal replacement therapy (RRT) at UK renal centres and did not have a recovery lasting more than 90 days within 90 days of starting RRT. The treatment timeline is used to define take-on patients as follows. If a patient has timeline entries from more than one centre then these are all combined and sorted by date. Then, the first treatment entry gives the first date of when they received RRT. This is defined as a ‘start date’. However, in the following situations there is evidence that the patient was already receiving RRT before this ‘start date’ and these people are not classed as takeon patients:
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom